共 29 条
[6]
Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor α antagonists and disease-modifying antirheumatic drugs
[J].
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH,
2007, 57 (02)
:343-346
[7]
Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists
[J].
ARTHRITIS AND RHEUMATISM,
2007, 56 (04)
:1125-1133
[8]
Predictors of infection in rheumatoid arthritis
[J].
ARTHRITIS AND RHEUMATISM,
2002, 46 (09)
:2294-2300

